Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bauknecht

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Clinical phase I study with one-hour paclitaxel infusionK Mross, B Hauns, B Häring, et al.
Journal of Virology|January 1, 1995
A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoterT Bauknecht, F Jundt, I Herr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancerA du Bois, H J Lück, T Bauknecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study GroupA du Bois, H J Lück, T Bauknecht, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 1999
Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapyA du Bois, M Schlaich, H J Lück, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 1995
Co-cultivation of ovarian carcinoma cells with dermal fibroblasts induces fibroblast expression of sex steroid receptor transcripts and proteinF. Kommoss, M. Kiechle-Schwarz, A. Dubois, et al.
International Journal of Cancer|April 22, 1996
Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesisP Dall, A Hekele, H Ikenberg, et al.
The Journal of Pathology|October 1, 1994
Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovaryF Kommoss, J Wölfle, T Bauknecht, et al.
Cancer|April 3, 2001
Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferationT Brandstetter, E Ninci, H Bettendorf, et al.
The Journal of Pathology|November 1, 1990
In situ distribution of transforming growth factor alpha in normal human tissues and in malignant tumours of the ovaryF Kommoss, H O Wintzer, S Von Kleist, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Clinical phase I study with one-hour paclitaxel infusionK Mross, B Hauns, B Häring, et al.
Journal of Virology|January 1, 1995
A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoterT Bauknecht, F Jundt, I Herr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancerA du Bois, H J Lück, T Bauknecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study GroupA du Bois, H J Lück, T Bauknecht, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 1999
Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapyA du Bois, M Schlaich, H J Lück, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 1995
Co-cultivation of ovarian carcinoma cells with dermal fibroblasts induces fibroblast expression of sex steroid receptor transcripts and proteinF. Kommoss, M. Kiechle-Schwarz, A. Dubois, et al.
International Journal of Cancer|April 22, 1996
Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesisP Dall, A Hekele, H Ikenberg, et al.
The Journal of Pathology|October 1, 1994
Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovaryF Kommoss, J Wölfle, T Bauknecht, et al.
Cancer|April 3, 2001
Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferationT Brandstetter, E Ninci, H Bettendorf, et al.
The Journal of Pathology|November 1, 1990
In situ distribution of transforming growth factor alpha in normal human tissues and in malignant tumours of the ovaryF Kommoss, H O Wintzer, S Von Kleist, et al.
Pageof 10